ABP-450
ABP-20002
Phase 2 small_molecule terminated
Quick answer
ABP-450 for Migraine is a Phase 2 program (small_molecule) at AEON Biopharma with 2 ClinicalTrials.gov record(s).
Program details
- Company
- AEON Biopharma
- Indication
- Migraine
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated